Thyroid Disorders

October 20, 2020

Check out this Emergency Department Minute Quiz from Brady Pregerson, MD. Can you determine the correct diagnosis?

October 19, 2020

Raymond Douglas, MD, PhD, discusses trends in treatment of thyroid eye disease and how the approval of teprotumumab has impacted the prospect of treating the condition.

October 06, 2020

How good are your diagnostic skills? Test them with this month's Visual Dx quiz!

October 01, 2020

Study suggests generic levothyroxine achieved similar rates of patients with thyrotropin levels in the ideal range as brand name levothyroxine.

September 21, 2020

Results of the study offer clinicians greater insight and could improve decision-making in regards to treatment choices for hypothyroidism.

September 19, 2020

A study from e-ECE 2020 suggests thyroid inflammation could put patients at greater risk for developing an anxiety disorder.

August 14, 2020

A survey of more than 600 physicians found many endorsed the use of thyroid ultrasonography for clinically unsupported reasons.

July 24, 2020

New research is comparing the long-term risk of death from solid cancers in patients treated with radioactive iodine, antithyroid drugs, or surgery for hyperthyroidism.

July 21, 2020

New data disputes the findings of previous observational studies examining the effects of levothyroxine on cardiac function.

May 21, 2020

A new case study published in The Journal of Clinical Endocrinology & Metabolism, reports on an 18-year-old patient with COVID-19 infection and subacute thyroiditis.

May 04, 2020

The common synthetic thyroid medication L-thyroxine has been shown to be ineffective in reducing symptoms in patients with subclinical hypothyroidism (SCH), according to a study published in the Annals of Internal Medicine.

April 14, 2020

New research shows teprotumumab can be a beneficial treatment for patients suffering from thyroid eye disease (TED), even across age, gender and risk factor-based subgroups. In an interview with HCPLive®, Raymond Douglas, MD, PhD, director of the Orbital and Thyroid Eye Disease Center at the Cedars-Sinai Medical Center, explained the importance of the teprotumumab in treating this patient group and how the coronavirus disease 2019 (COVID-19) might impact thyroid eye disease patients.

January 22, 2020

The FDA announced yesterday that it has approved the first treatment for thyroid eye disease:  teprotumumab-trbw (Tepezza, Horizon Therapeutics).

May 22, 2019

Restoring normal thyroid function may reverse cold-induced thermogenesis, say researchers writing in the journal Thyroid.

May 22, 2019

Adults with subclinical hypothyroidism do not need thyroid hormone therapy in most cases, states a BMJ Rapid Recommendation issued this month.

May 15, 2019

Thyroid hormones have a wide range of effects of the cardiovascular system. Too much or too little thyroiid hormones can induce or exacerbate existing cardiovascular disorders. In this article, we highlight the treatment recommendations for thyroid-related CVD events.

May 01, 2019

Healthcare providers are increasingly looking for signs of opioid-induced adrenal insufficiency (OIAI) in their patients, according to a presentation made at the AACE annual meeting held in Los Angeles last week.

April 03, 2019

Primary care providers, endocrinologists and obstetricians have been challenged with the question of whether to screen all pregnant women for thyroid disease. The debate springs primarily from unknown clinical implications of subclinical thyroid disease during pregnancy. This issue was addressed at ENDO 2019.

February 14, 2019

Despite conflicting guidelines on how to treat hypothyroidism, U.S. physicians prescribe combination therapy more often than physicians around the world.

November 21, 2016

Our November list includes an injectable male contraceptive, resveratrol treatment for PCOS, and novel gene associated with Addison disease.